Source: FDA, National Drug Code (US) Revision Year: 2021
Paromomycin sulfate is indicated for intestinal amebiasis–acute and chronic (NOTE-It is not effective in extraintestinal amebiasis); management of hepatic coma–as adjunctive therapy.
To reduce the development of drug-resistant bacteria and maintain the effectiveness of HUMATIN Capsules and other antibacterial drugs, HUMATIN Capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
Intestinal amebiasis: Adults and Pediatric Patients: Usual dose – 25 to 35 mg/kg body weight daily, administered in three doses with meals, for five to ten days.
Management of hepatic coma:
Adults: Usual dose – 4 g daily in divided doses, given at regular intervals for five to six days.
Store at 20°-25°C (68°-77°F) [See USP controlled Room Temperature].
Protect from moisture.
Preserve in tight containers as defined in the USP.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
